Dundas Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.9M | Sell |
97,396
-1,010
| -1% | -$548K | 3.82% | 10 |
|
|
2025
Q4 | $57M | Buy |
98,406
+3,175
| +3% | +$1.8M | 4.02% | 9 |
|
|
2025
Q3 | $46.2M | Buy |
95,231
+2,038
| +2% | +$949K | 3.26% | 14 |
|
|
2025
Q2 | $37.8M | Buy |
93,193
+18,041
| +24% | +$7.54M | 2.63% | 18 |
|
|
2025
Q1 | $37.4M | Buy |
75,152
+4,914
| +7% | +$2.66M | 2.75% | 17 |
|
|
2024
Q4 | $36.5M | Hold |
70,238
| – | – | 2.56% | 19 |
|
|
2024
Q3 | $43.4M | Hold |
70,238
| – | – | 3.13% | 12 |
|
|
2024
Q2 | $38.8M | Buy |
70,238
+664
| +1% | +$380K | 3.01% | 12 |
|
|
2024
Q1 | $40.4M | Buy |
69,574
+6,923
| +11% | +$3.88M | 3.18% | 11 |
|
|
2023
Q4 | $33.3M | Buy |
62,651
+886
| +1% | +$429K | 2.9% | 16 |
|
|
2023
Q3 | $31.3M | Buy |
61,765
+8,477
| +16% | +$4.52M | 3.07% | 14 |
|
|
2023
Q2 | $27.8M | Hold |
53,288
| – | – | 2.62% | 22 |
|
|
2023
Q1 | $30.7M | Sell |
53,288
-137
| -0.3% | -$77.2K | 3.21% | 11 |
|
|
2022
Q4 | $29.4M | Buy |
53,425
+849
| +2% | +$450K | 3.2% | 13 |
|
|
2022
Q3 | $26.7M | Hold |
52,576
| – | – | 3.1% | 13 |
|
|
2022
Q2 | $28.6M | Hold |
52,576
| – | – | 3.09% | 11 |
|
|
2022
Q1 | $31.1M | Buy |
52,576
+11,730
| +29% | +$6.74M | 2.82% | 16 |
|
|
2021
Q4 | $23.5M | Buy |
40,846
+2,278
| +6% | +$1.42M | 2.92% | 16 |
|
|
2021
Q3 | $22M | Hold |
38,568
| – | – | 3.11% | 13 |
|
|
2021
Q2 | $19.5M | Hold |
38,568
| – | – | 2.82% | 16 |
|
|
2021
Q1 | $17.6M | Hold |
38,568
| – | – | 2.79% | 16 |
|
|
2020
Q4 | $21.5M | Hold |
38,568
| – | – | 3.14% | 13 |
|
|
2020
Q3 | $17M | Hold |
38,568
| – | – | 3.42% | 10 |
|
|
2020
Q2 | $14M | Hold |
38,568
| – | – | 3.06% | 14 |
|
|
2020
Q1 | $11M | Hold |
38,568
| – | – | 2.87% | 16 |
|
|
2019
Q4 | $12.5M | Hold |
38,568
| – | – | 2.83% | 19 |
|
|
2019
Q3 | $11.2M | Hold |
38,568
| – | – | 2.8% | 19 |
|
|
2019
Q2 | $11.3M | Buy |
38,568
+350
| +0.9% | +$96.4K | 2.65% | 18 |
|
|
2019
Q1 | $10.4M | Hold |
38,218
| – | – | 2.56% | 20 |
|
|
2018
Q4 | $11.2M | Hold |
38,218
| – | – | 2.45% | 22 |
|
|
2018
Q3 | $11.9M | Buy |
38,218
+8,397
| +28% | +$1.93M | 2.41% | 26 |
|
|
2018
Q2 | $6.19M | Sell |
29,821
-6,402
| -18% | -$1.36M | 2.11% | 25 |
|
|
2018
Q1 | $7.1M | Buy |
+36,223
| New | +$7.6M | 2.2% | 26 |
|
Other funds holding TMO
VCM
Dundas Partners's TMO Position: Q1 2026 in Review
Dundas Partners reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q1 2026, selling an estimated $548K and leaving 97,396 shares worth $47.9M. The position accounts for 3.82% of the portfolio, ranked #10.
Dundas Partners first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $57M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Dundas Partners held 97,396 shares of Thermo Fisher Scientific worth $47.9M as of Q1 2026.
- Dundas Partners sold 1,010 Thermo Fisher Scientific shares in Q1 2026, an estimated $548K.
- Thermo Fisher Scientific made up 3.82% of Dundas Partners's portfolio in Q1 2026, its #10 holding.
- Dundas Partners first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Dundas Partners's Thermo Fisher Scientific position peaked at $57M in Q4 2025.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Dundas Partners's 13F filing for Q1 2026, filed 14 May 2026.